Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. life science technology
Show results for
Products
Services
Training

Companies

News
Articles

Refine by
Date

  • Older

Life Science Technology Articles & Analysis

28 news found

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. Michael’s Hospital, with support from OBIO’s Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence. ...

BySynaptive Medical


CD Genomics Debuts Next-Generation Nanopore Sequencing Services for Unlocking Genomic Secrets

CD Genomics Debuts Next-Generation Nanopore Sequencing Services for Unlocking Genomic Secrets

CD Genomics, a leading provider of genomic research solutions, today announced the launch of its cutting-edge Nanopore sequencing services, marking a significant advancement in DNA and RNA analysis capabilities. This innovative technology, developed by Oxford Nanopore Technologies, is set to transform the landscape of life ...

ByCD Genomics


TOMI to Attend Three Leading Pharmaceutical Conferences in the First Quarter of 2023

TOMI to Attend Three Leading Pharmaceutical Conferences in the First Quarter of 2023

® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces that TOMI will present its SteraMist brand of products at three upcoming International Society for Pharmaceutical Engineering (ISPE) Conferences in the first quarter of 2023: The ISPE Facilities of the Future Conference, to be held in Bethesda, MD, January 31-Febraury ...

BySteraMist Disinfection


Alfa Chemistry Combines the Power of Computational Chemistry for Multiple Medical Applications

Alfa Chemistry Combines the Power of Computational Chemistry for Multiple Medical Applications

Devoted to integrating computational chemistry according to customers’ needs, Alfa Chemistry behaves well in the following areas: Computer Aided Drug Design Driven by advanced computer technology, computer-aided drug design is of paramount significance to the design of lead compounds and has achieved great progress in recent years. ...

ByAlfa Chemistry


Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Gustavo was most recently a Venture Partner with DYNAMK Capital where he invested in leading life sciences tools, technologies, and services. Prior to this role Gustavo spent ten years leading and growing CMC Biologics (now AGC Biologics) resulting in CMC’s sale to Asahi Glass Corporation for €520 million which created AGC Biologics. ...

ByNcardia Services B.V.


Cellworks Wins Dell Technologies The Challengers 2022 Innovative Business of the Year Award

Cellworks Wins Dell Technologies The Challengers 2022 Innovative Business of the Year Award

Cellworks Group, Inc., a world leader in Genomic Biosimulation Services for Precision Pharma and Personalized Oncology, today announced it has won The Challengers Innovative Business of the Year Award. Dell Technologies, in collaboration with Moneycontrol, CNBC TV-18, Intel, and Ernst and Young, established The Challengers Awards to recognize the agility and innovation displayed ...

ByCellworks Research India Private Limited


Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data

Kyowa Kirin Expands License Agreement with Synaffix and Takes Exclusive Target Rights Based on Latest Positive ADC Data

(Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:4151), a global specialty pharmaceutical company that strives to create new value through the pursuit of advances in ...

BySynaffix BV


Proprio Expands Board of Directors to Include Pioneering Surgeon & Venture Capitalist Dr. Linda Maxwell

Proprio Expands Board of Directors to Include Pioneering Surgeon & Venture Capitalist Dr. Linda Maxwell

Proprio, a medical technology company enabling enhanced surgical performance through the proprietary combination of computer vision, machine learning, and immersive technology, is pleased to announce Dr. ...

ByProprio, Inc.


Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer

Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer

Capricor Expands Senior Management Team to Build Commercial Strategy for Lead Asset, CAP-1002, and Further Develop Partnering Strategy for Proprietary Exosome Platform Formerly at Edwards Lifesciences, Gilead and Genentech, Mr. Avat Brings Over 25 Years of Business and Commercial Strategy Experience to Capricor Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company focused on the ...

ByCapricor Therapeutics, Inc.


Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market

HealthCor stated a focus on the healthcare industry in the United States and other developed countries, with particular interest in the life sciences and medical technology sectors. About Hyperfine Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. ...

ByHyperfine


Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

About the LSX 6th Annual Investment Showcase The Investment Showcase is an international showcase of early, growth stage and public life science and health technology companies, Investment Showcase provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European ...

ByBerkshire Biomedical


Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital. Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital. Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

(NYSE: HTGC), a specialty financing lender for life science and technology companies. The funds under the facility will be available in tranches upon the achievement of specific clinical and business milestones. ...

ByLocus Biosciences, Inc.


TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage

TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage

Affiliated to Cathay Capital, Cathay Health is a global cross-border platform investing at the convergence of healthcare, life sciences and technology. By helping navigate the opportunities of globalization and sustainable transformation, Cathay is the partner of choice for companies aspiring to lead markets and make a positive impact. ...

ByTISSIUM


Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia - PharmiWeb.com

Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia - PharmiWeb.com

The Board of Directors will be comprised of Chris Garabedian, CEO of Xontogeny, Gianna Hoffman-Luca, Senior Associate at Xontogeny, Shaker Mousa, Professor and Chairman at Albany College of Pharmacy and Health Sciences, and Sherin Abdel-Meguid, President of Shifa. About P-21 P-21 is an orally bioavailable, small molecule that interferes with the function of PCSK9. ...

ByShifa Biomedical Corporation


Vaxdyn brings muscle to its strategy with new investments from Bionova Capital and Arquimea Group

Vaxdyn brings muscle to its strategy with new investments from Bionova Capital and Arquimea Group

Bionova Capital is a leading venture capital firm investing in and building disruptive life science companies across Europe. Led by the highly experienced pharmaceutical entrepreneur Peter Villax (chairman) and life science investor Ricardo Perdigão Henriques (CEO), Bionova Capital brings key strategic value to Vaxdyn. ...

ByVaxdyn, S. L.


OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

OtoNexus Medical Technologies Wins Prestigious Most Valued Company Award at Keiretsu Forum Investor Capital Expo

Keiretsu Forum announced today that OtoNexus Medical Technologies was named 'Most Valued Company' at the virtual Keiretsu Forum Investor Capital Expo. ...

ByOtoNexus Medical Technologies Inc.


MedTech Innovator Announces Finalists for $500K 8th Annual Industry Accelerator Competition

MedTech Innovator Announces Finalists for $500K 8th Annual Industry Accelerator Competition

MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. Virtual attendees of The MedTech Conference, the largest gathering of medtech industry leaders in North America, powered by AdvaMed, will vote online to choose the ...

ByMoray Medical


JenaValve Technology Closes $50 Million Financing

JenaValve Technology Closes $50 Million Financing

JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. ...

ByJenaValve Technology, Inc.


Nanovis Announces Commercial Launch of New Nanosurface Technology on Spinal Interbody Implants

Nanovis Announces Commercial Launch of New Nanosurface Technology on Spinal Interbody Implants

Its industry-leading fixation technologies offer surgeons and hospitals the best aspects of fixation, visualization, and durability. ...

ByNanovis


Nanovis Named MedTech Outlook Top 10 Orthopedic Solution Provider 2019

Nanovis Named MedTech Outlook Top 10 Orthopedic Solution Provider 2019

” Nanovis’ fixation technology platforms continue to perform well commercially and in testing. ...

ByNanovis

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT